Umeme Limited (NASE:UMME)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions KES. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	24,330	23,619	26,910	14,843	9,802	10,648
Market Cap Growth	-12.23%	-12.23%	81.30%	51.42%	-7.94%	2.32%
Enterprise Value	25,242	24,908	30,041	24,264	24,169	27,672
PE Ratio	-	-	56.63	3.01	2.21	8.26
PS Ratio	0.30	0.29	0.30	0.24	0.16	0.21
PB Ratio	2.87	2.79	0.69	0.44	0.34	0.44
P/OCF Ratio	2.38	2.31	1.41	1.28	0.97	1.28
EV/Sales Ratio	0.30	0.31	0.33	0.39	0.40	0.56
EV/EBITDA Ratio	5.93	6.03	1.50	1.90	1.88	3.73
EV/EBIT Ratio	-	-	14.40	3.25	3.10	7.87
Debt / Equity Ratio	0.24	0.24	0.10	0.30	0.48	0.75
Debt / EBITDA Ratio	0.49	0.49	0.19	0.79	1.07	2.42
Quick Ratio	0.33	0.33	0.31	0.37	0.38	0.39
Current Ratio	1.21	1.21	0.68	0.46	0.51	0.54
Asset Turnover	1.24	1.24	0.89	0.74	0.73	0.64
Return on Equity (ROE)	-86.62%	-86.62%	1.18%	15.57%	16.41%	5.26%
Return on Assets (ROA)	-11.38%	-11.38%	1.28%	5.53%	5.90%	2.82%
Return on Capital (ROIC)	-32.02%	-32.02%	2.69%	10.65%	11.19%	5.17%
Return on Capital Employed (ROCE)	-	-	4.50%	14.10%	15.10%	7.00%
Earnings Yield	-73.55%	-75.76%	1.77%	33.19%	45.34%	12.11%
Earnings Yield	-73.55%	-75.76%	1.77%	33.19%	45.34%	12.11%
Dividend Yield	84.28%	8.90%	42.97%	71.56%	81.30%	16.95%
Payout Ratio	-	-	904.54%	59.25%	14.24%	155.82%
Total Shareholder Return	84.28%	8.90%	42.97%	71.56%	81.30%	16.95%

Source: S&P Global Market Intelligence. Utility template. Financial Sources.